Concentration of fentanyl in colostrum after an analgesic dose
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0,40 +. _ 0,059 ng 9 ml-t mais elles dtaient virtuellement inddterminables dix heures plus tard. Les concentrations de fentanyl ~taient toujours plus ~levdes dans le colostrum que dans le s~rum. En conclusion, avec ces faibles concentrations et dtant donn~e la faible biodisponibiliM du fentanyl administrd par voie orale, l' analgdsie intraveineuse au moyen de fentanyl peut @tre utilis~e de fafon s~curitaire chez les femmes qui allaitent.
Fentanyl is frequently used to provide analgesia or anaesthesia to women during the postpartum period. Although mammary excretion of other anaesthetics and analgesics has recently been studied, the excretion of fentanyl into breast milk has not been examined.l-6 Fentanyl is a potent synthetic phenylpiperidine with an extremely high lipid solubility and high pKa. Thus, it should have a propensity for accumulation in breast milk. Postpartum women who have had anaesthesia often inquire about the amount of drugs transferred to their newborns through their breast milk. In particular, many women receive fentanyl as part of the anaesthetic/analgesic regimen for common procedures such as Caesarean section or postpartum tubal ligation. Since this is such a common concern, the primary aim of this preliminary study was to measure the concentrations of fentanyl present in serum and colostrum after administration of a typical intravenous analgesic dose of fentanyl.
Methods
Institutional approval was granted by the Human Subjects Committee of the University of Kansas Medical Center. Further approval was granted by the administrative board of Poudre Valley Hospital, Fort Collins, Colorado, where the research was conducted. Following informed consent, 2 lag" kg -l intravenous fentanyl was administered to 13 healthy women undergoing either an elective Caesarean section or a postpartum tubal ligation.
Women (n = 8) undergoing Caesarean section were prepared for surgery in the usual manner. After a 1500 ml fluid bolus, a spinal anaesthetic of bupivacaine 0.75% was administered. Ephedrine was given intravenously as needed to keep the systolic blood pressure greater than 100 mmHg. The patient was positioned with a left lateral tilt and monitored with an automated non-invasive blood pressure cuff, electrocardiogram and pulse oximeter during the Caesarean section. After delivery and cord clamping, an analgesic dose of fentanyl, 2 I~g" kg -I, was administered iv. Any need for additional analgesia was met with either morphine or meperidine. For women (n = 5) undergoing postpartum tubal ligation, an analgesic dose of fentanyl, 2 ~g. kg -1, was administered over 15 min prior to the induction of general anaesthesia. Following preoxygenation for four minutes, anaesthesia was induced with thiopentone, using a rapidsequence technique. Tracheal intubation was facilitated by succinylcholine. Anaesthesia was maintained with isoflurane 0.5-1.5% with 30% oxygen in nitrous oxide.
Blood and colostrum samples were taken from each woman at 45 min, two, four, six, eight, and ten hours after the fentanyl was given. Sampling was done for all patients at 45 min, then samples were collected by one of three different sampling time protocols, as illustrated in Tables  I and II . These patterns were designed to obtain a comprehensive view of fentanyl's concentrations over time, without excessively or repetitively sampling from each woman every two hours. In most women, colostrum was not available in amounts sufficient to collect samples every two hours over a period of ten hours, To facilitate the collection of blood samples, a threeway stopcock was incorporated into the intravenous line. Five milliliters of blood were withdrawn from the preexisting iv catheter into glass test tubes. After clotting, the blood was centrifuged for five minutes. The serum was extracted and frozen at -20 ~ C until analysis could be accomplished. Colostrum was simultaneously collected using an electric breast pump, facilitated by gentle manual expression. Two ml of colostrum were collected from the same breast at each sample time and frozen at -20 ~ C until analysis. For samples collected from breast-feeding mothers, the colostrum was taken after the newborn nursed.
Serum and colostrum samples were analysed for fentanyl by Rocky Mountain Instrumental Laboratories of Fort Collins, Colorado. Analysis was by solid phase radioimmunoassay, validated by gas chromatography/mass spectrometry. 
Results
Radioimmunoassay showed that fentanyl appeared in colostrum. The highest concentration, at the times measured, was 0.40 _+ 0.059 rag. ml -I 45 min after intravenous administration. At this initial sampling time serum concentrations were also maximal, reaching 0.19 _+ 0.019 ng. m1-1. Fentanyl concentrations were greater in colostrum than in serum during all times measured. Fentanyl became undetectable in the blood by two hours after administration. It was virtually undetectable in colostrum by the tenth hour after the analgesic dose was administered (Tables I and II) . The decay of fentanyl in serum and colostrum over time is shown in the Figure. Demographic patient data are illustrated in Table III .
Discussion
Radioimmunoassay (RIA) has been used to evaluate fentanyl concentrations in serum, cerebrospinal fluid and urine. 7'8 Gas chromatography also has been advocated as a sensitive method of serum fentanyl measurements. 9-11 Laboratory analyses for serum fentanyl were performed by solid phase radioimmunoassay and validated by gas chromatography/mass spectrometry. Fentanyl has not been previously quantified in colostrum. Laboratory analyses for colostrum fentanyl concentration in this study were performed using solid phase radioimmunoassay (RIA) and validated by gas chromatography/mass spectometry. A pilot test, using multiple samples of human urine and goat's colostrum, and one sample of human colostrum, each containing known quantities of fentanyl, examined the recovery of fentanyl. Goat's colostrum was chosen because its content is physiochemically close to that of human colostrum.~2 The recovery of fentanyl from human colostrum and goat colostrum was 100%. Precision for the RIA was 5.1% RSD at the 1 ng. ml -l level. The correlation coefficient for the log-logit plot was 0.9942, and the limit of detection was 0.05 ng. ml -l. All control sample results were within the target ranges specified by the manufacturer. Standards prepared in urine resulted in log-logit plots identical to those prepared on goat colostrum. The detection limit for the gas chromatography/mass spectometry was 0.05 ng. ml -j, and the precision for the assay at 1 ng. ml -I was 12.9%. No cross-reactivity was detected at any concentration for norfentanyl or despropionyl fentanyl, the two major metabolites of fentanyl.
An inherent limitation in this study was the previously untested laboratory technique chosen for analysis of fentanyl in colostrum. The amount of fentanyl could have been below the limits of detection. However, if fentanyl concentrations were below the detection limits, this information supports the safety of breast feeding after the administration of analgesic doses of fentanyl.
Although the study was limited to 13 patients, the results agree closely with the published results of morphine in colostrum. 6 Fentanyl, like morphine, has an alkaline pKa, in contrast to the more acidic breast milk. Based on this and its extreme lipophilicity, one would expect it to accumulate in colostrum. Fentanyl is one of the most lipophilic narcotics, as measured by its octanol:water coefficient. This characteristic should confer a passive transfer across biologic membranes, such as the mammary epithelium. Once inside the milk compartment, fentanyl is thought to ionize and become trapped in the acidic colostrum. This is a likely reason for a milk-to-plasma concentration ratio (M/P ratio) greater than one.
The use of three different sampling time protocols to avoid excessive or repetitive sampling from each woman was a limitation of the study. However, an overview of serum and colostrum fentanyl concentrations over time was attained. The rapid decline in serum and colostrum over time could be explained primarily in terms of fentanyl's large volume of distribution and, also, short beta elimination half-life. The absorption, distribution, metabolism and elimination Of fentanyl have been described in detail by Hug, 13 who found that the pharmacokinetic behavior of fentanyl was independent of dose. An intravenous dose rapidly distributes to the central compartment, consisting of the vessel-rich organs such as the heart, brain, lung and liver. Following this, it redistributes to the more peripheral compartments, such as muscle and fat. This sequestration to a large volume of distribution limits further fentanyl delivery to the breast. The elimination via metabolic processes gives fentanyl a beta elimination halflife of approximately 219 min which also limits the amount of drug available for continued transport to the breast. This hepatic biotransformation and redistribution to the peripheral body stores explains the decline in serum and colostrum with time. Unfortunately, peak serum and colostrum fentanyl levels may have been missed due to the first and second samples being taken 45 and 120 min after fentanyl administration. In most cases, few mothers were able to nurse within 45 min of the induction anaesthesia. In addition, these sampling times were chosen to allow for mother-baby bonding.
Although breast feeding often occurs after the mother has had an anaesthetic, the effects of many drugs on the neonate have not been elucidated. Koehntop et al. 14 determined that neonates younger than 14 days succumb to respiratory depression at lower serum levels of fentanyl than infants, children and adults. The oral bioavailability of fentanyl lies between 0-49%, and the transmucosalbioavailability is 49%. 15-17 Several physiological factors combine to make the neonate more vulnerable to drug toxicities. Metabolic and elimination pathways at birth are functioning at only a fraction of adult capacities. Protein binding of drugs is diminished quantitatively and qualitatively in the neonate, which permits more drug to be free for action at its receptor site. The respiratory chemoreceptors have a decreased sensitivity to carbon dioxide and hypoxia at birth. Considering these factors, if any doubt exists concerning the safety of breast feeding, the mother should be advised to pump her breasts to maintain lactation and resume nursing at a later time. Principal factors which determine neonatal effects from drug exposure through breast milk include the maternal dose, the volume of milk consumed and the child's postconceptual age.
This study showed that fentanyl does appear in colostrum after an analgesic dose. However, considering the small and fleeting amount of fentanyl detected in colostrum, full-term infants should not be restricted from breast feeding. Neonates consume very little colostrum in the first few days of life, but gradually increase their intake to an average 150 ml. kg -l. day-I. Is Taking the worst example, the amount of fentanyl a neonate is likely to receive is extremely small. If one assumes a concentration of fentanyl as high as 1 ng. ml -I in colostrum and if the baby ingests as much as 100 ml, the neonate could receive 100 ng of fentanyl po. Assuming 49% bioavailability, and a three kilogram infant, this represents a dose of 0.016 I~g" kg -l. It would be surprising if such a low dose would produce any deleterious effects.
Considering the large number of women receiving ptiarmacological care, the investigation of drugs in breast milk remains unexplored. Future studies should be conducted to validate the fentanyl analysis in colostrum and full neonatal neurobehavioural responses following exposure to fentanyl via breast milk. However, this study has shown that fentanyl appears in colostrum after an analgesic dose but the transfer of fentanyl to the neonate via colostrum is very low.
